Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lois M Ramondetta
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Lyndon Baines Johnson General Hospital
Houston, Texas, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- Md Anderson in Katy
Houston, Texas, United States
- the Woman'S Hospital of Texas
Houston, Texas, United States
- Md Anderson in Sugar Land
Sugar Land, Texas, United States
- Md Anderson in the Woodlands
The Woodlands, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Mar 2012
- Primary completion
- 15 Aug 2019
- Completion
- 15 Aug 2019
- Last update posted
- 29 Aug 2019
- Registered enrollment
- 32
- Registry id
- NCT01504126
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.